Compugen Publishes Paper in Cancer Immunology Research on Unique Biology of PVRIG and its Therapeutic Potential

Go back to Compugen Publishes Paper in Cancer Immunology Research on Unique Biology of PVRIG and its Therapeutic Potential
Compugen Ltd (NASDAQ: CGEN) Delayed: 2.08 +0.07 (3.48%)
Previous Close $2.01    52 Week High $7.79 
Open $2.02    52 Week Low $4.32 
Day High $2.10    P/E N/A 
Day Low $2.02    EPS $-0.36 
Volume 141,221       

Compugen Ltd (NASDAQ: CGEN) Delayed: 2.08 +0.07 (3.48%)
Previous Close $2.01    52 Week High $7.79 
Open $2.02    52 Week Low $4.32 
Day High $2.10    P/E N/A 
Day Low $2.02    EPS $-0.36 
Volume 141,221